Skin Cancer, Take a Hike! – Following the Journey of Dr. Dan Siegel
It is estimated that someone dies from melanoma ever hour, and one in five Americans will be diagnosed with skin cancer. However, when skin cancer is detected early, it has a 98% cure rate. Dr. Dan Siegel is embarking on a journey through the Alaskan wilderness to spread awareness, detection and prevention of skin cancer […]
What Does Basal Cell Carcinoma Look Like?
Basal cell carcinoma is a form of skin cancer that grows on areas of skin that are exposed to a lot of sunlight and UV radiation. If you’ve found a suspicious-looking spot on your skin that you think might be basal cell carcinoma, it’s natural to feel worried and scared. This is why it’s important […]
The Benefits of Treating Non-Melanoma Skin Cancer with Superficial Radio Therapy
When patients are diagnosed with non-melanoma skin cancers like basal cell carcinoma and squamous cell carcinoma, the first questions they ask are typically along the lines of… What does this mean? How serious is this? Is this life threatening? What is the survival rate? How can this be treated? That last question tends to be […]
Dr. Kevin Schewe, M.D. Discusses SRT
Dr. Kevin Schewe, M.D. discusses the early signs and symptoms of skin cancer plus the revolutionary treatment of SRT. View the full interview with 9News.com here.
NBNA – SRT-100, Game Changer for Keloid Treatment
Dr. Michael H. Gold, a previously featured physician in our Physician Spotlight, has been featured in the Fall 2017 issue of National Black Nurses Association News. Read the article here. SRT-100, Game Changer for Keloid Treatment Treating keloids is very frustrating, not only for the patient suffering from them, but also for the health care […]
Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe
BOCA RATON, Fla., Feb. 7, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that the Company is opening a new office in Tel Aviv to deepen its presence in Israel, the Middle East and […]
Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World
BOCA RATON, Fla., Feb. 5, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today Sensus’ collaboration with BirchBioMed Inc., a biomedical company focused on anti-scarring drugs, to treat and prevent scarring more effectively for patients […]
The Surgeon General’s Call to Action to Prevent Skin Cancer
The Surgeon General has released a Call to Action to address Skin Cancer as a major public health problem. The executive summary includes strategies for prevention with clear and concisely outlined goals. Click the link below to read the full article. The Surgeon General’s Call to Action to Prevent Skin Cancer
Sensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full Year
Ninth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 1, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three […]
